[Home]
[Reports] [Startups]
[Press Releases] [ONLINE
STORE] [site map]
[Home]
[Reports] [Startups]
[Press Releases] [ONLINE
STORE] [site map]
 Developments |
Financings |
Reports |
Startups |
Blog |
Podcast |
Cardiology |
Surgery |
|
A Worldwide Business Report Download the report
now
Single user
Worldwide Surgical Sealants, Glues,
Wound Closure and Anti-Adhesion Markets, 2010-2015 A worldwide report on the products, technologies and markets in wound closure and anti-adhesion.
· 262 pages
· 53 Exhibits
· 104 Company Profiles
· Report #S180
· October 2010 Price: $3,750 (print or PDF; add $200 for both). Order online
or via
order
form. This report details the complete range of
sealants & glues technologies used in traumatic, surgical and other
wound closure, from tapes, sutures and staples to hemostats, fibrin
sealants/glues and medical adhesives. The report details current
clinical and technology developments in this huge and rapidly growing
worldwide market, with data on products in development and on the
market; market size and forecast; competitor market shares; competitor
profiles; and market opportunity.
This report is a
market and technology assessment and forecast of surgical sealants,
glues, hemostasis, other wound closure and anti-adhesion. The report
details the current and emerging products, technologies and markets
involved in wound closure and sealing using sutures and staples, tapes,
hemostats, fibrin and sealant products, medical adhesives and products
to prevent surgical adhesions. With full year actual data from 2009
and, for many companies, two quarters of actual data from 2010, the
report provides a worldwide forecast to 2015 of the markets for these technologies, with
particular emphasis on the market impact of new technologies through the
coming decade. The report provides specific forecasts and shares
of the worldwide market by segment for the U.S., Europe (United Kingdom,
German, France, Italy, BeNeLux), Latin America, Japan, Korea and Rest of World.
The report provides
background data on the surgical, disease and traumatic wound patient
populations targeted by current technologies and those under
development, and the current clinical practices in the management of
these patients, including the dynamics among the various clinical
specialties or subspecialties vying for patient population and
facilitating or limiting the growth of technologies.
The report
establishes the current worldwide market size for major technology
segments as a baseline for and projecting growth in the market over a
five-year forecast. The report also assesses and projects the composition
of the market as technologies gain or lose relative market performance
over this period.
Table of Contents EXECUTIVE SUMMARY Introduction
Demographic Trends
Consumer-Driven Product Selection
Mechanisms of Tissue Repair
Commercial Imperatives
Industry Consolidation
Clinical Caseload
Market Segmentation and
Dynamics
New Surgical Techniques Drive
Market Opportunity
The Uses of Adjunctive
Surgical Closure and Securement Products
Product Development History
Evolution of Commercial
Markets for Sealants and Adhesives
Overview of Company Strategies
SECTION 1: CLINICAL NEED, CASELOAD, AND PROCEDURE VOLUMES 1.1 Anatomy and Physiology of Tissue Repair 1.2 The Skin
1.3 Internal Tissues and
Organs
1.4 Wound Classification and
Types
1.4.1 Classification by Morphology and Severity
1.4.2 Wound Classification by Cause
1.4.3 Surgical Wounds
1.5 Caseload
1.5.1 Cardiovascular
1.5.1.1 Coronary Heart Disease
1.5.1.2 Dysfunctional Heart Valves
1.5.1.3 Peripheral Vascular Disorders
1.5.1.4 Abnormal Aortic Aneurysms
1.5.1.5 Drivers of Caseloads for Cardiac Surgery
1.5.2 Neurological
1.5.2.1 Stroke
1.5.2.2 Parkinson’s Disease
1.5.2.3 Epilepsy
1.5.2.4 Traumatic Injury
1.5.2.5 Peripheral Nerve Treatment
1.5.2.6 Neurology Drivers
1.5.3 Orthopedic
1.5.3.1 Hip Replacements
1.5.3.2 Knee Replacements
1.5.3.3 Cartilage Repair
1.5.3.4 Ligament Damage
1.5.3.5 Bone Grafting
1.5.3.6 Vertebral Disc Repair
1.5.3.7 Drivers of Orthopedic Surgery
1.5.4 Urological
1.5.4.1 Incontinence
1.5.4.2 Drivers of Urological Surgery
1.5.5 Skin
1.5.5.1 Burns
1.5.5.2 Pressure Ulcers
1.5.5.3 Diabetic Ulcers
1.5.5.4 Venous Ulcers
1.5.5.5 Plastic Surgery
1.6 The Role of Modern Sealant, Securement and Hemostatic Products in
Surgery
1.6.1 Fibrin Sealants
1.6.2 High-Strength Glues
SECTION 2: SCIENCE, TECHNOLOGY, DEVELOPMENT, CLINICAL AND REGULATORY
CHALLENGES
2.1 Tissue Healing
2.1.1 Hemostasis
2.1.2 Proliferation and Maturation
2.1.3 Factors That Affect Healing
2.2 Product Development
2.3 Development Timelines
2.3.1 Collagen and Thrombin Combination
2.3.2 Polyethylene Glycol Polymer (PEG)
2.3.3 Albumin Cross-Linked with Glutaraldehyde
2.3.4 Delivery Systems
2.4 Cost-Effectiveness
2.5 Regulatory Challenges
2.5.1 Approval Processes .
2.5.2 History of Product Development
2.5.3 Regulatory Aspects
SECTION 3: PRODUCTS, TECHNOLOGIES, AND FORECAST OPPORTUNITY
3.1 Overview
3.2 Development Timeline
3.3 Sutures, Staples, and
Other Mechanical Closure Devices
3.3.1 Sutures, Staples and Mechanical Closure Competitors and
Products
3.3.2 Sutures, Staples and Mechanical Closure Products in
Development
3.3.3 Sutures, Staples and Mechanical Closure Market Analysis and
Forecast
3.4 Tapes
3.4.1 Medical Tape Competitors and Products
3.4.2 Medical Tape Market Analysis and Forecast
3.5 Hemostats
3.5.1 Hemostat Competitors and Products
3.5.2 Hemostat Products in Development
3.5.3 Hemostat Market Analysis and Forecasts
3.6 Fibrin and Other Sealant
Products
3.6.1 Fibrin and Other Sealant Competitors and Products
3.6.2 Fibrin and Other Sealant Products in Development
3.6.3 Fibrin and Sealant Market Analysis and Forecasts
3.7 High-Strength Medical
Adhesives
3.7.1 High-Strength Medical Adhesive Competitors and Products
3.7.2 High-Strength Medical Adhesive Products in Development
3.7.3 High-Strength Medical Adhesive Market Analysis and
Forecasts
3.8 Post-Surgical Adhesion
Prevention
3.8.1 Post-Surgical Adhesion Prevention Competitors and Products
3.8.2 Post-Surgical Adhesion Prevention Products in Development
3.8.3 Post-Surgical Adhesion Prevention Market Analysis and
Forecasts
3.9 Wound Closure and
Securement Markets: Global and Regional Analysis
3.9.1 Americas
3.9.1.1 United States
3.9.1.2 Latin America
3.9.2 Japan and Korea
3.9.3 Europe
3.9.4 Rest of World
3.10 Worldwide Markets By
Country and Segment
SECTION 4: COMPANY PROFILES
3DM, Inc. (3D-Matrix, Ltd.)
3M
Abbott Laboratories
AccessClosure, Inc.
Adhezion Biomedical, LLC
Advanced Medical Solutions plc/Medlogic Global
Aeris Therapeutics
Angiotech Pharmaceuticals, Inc.
Anika Therapeutics, Inc.
ARC Pharmaceuticals
Arch Therapeutics, Inc.
ArthroCare Corporation
Aso LLC
Aspen Surgical Products
Avery Dennison
B. Braun (Braun Melsungen AG
Baxter International Inc.
Berlin Heart GmbH
Bernsco Surgical Supply (George Tiemann & Co.)
Biocoral Inc.
BIOSTER a.s.
BSN Medical
C.R. Bard (Bard Medical, Davol)
Cardiva Medical, Inc.
Ceremed, Inc.
Chemence Medical
Cohera Medical, Inc.
Collagen Matrix, Inc.
Coloplast A/S
Covidien Ltd.
CryoLife Inc.
CSIRO PhotoMedical Technologies
CSL Behring
CSMG Technologies, Inc. (Live Tissue Connect, Inc.)
CuraMedical BV
Derma Sciences, Inc.
DuPont Applied BioSciences
Entegrion, Inc.
FibroGen, Inc.
Fidia Advanced Biopolymers
FzioMed Inc.
Gelita Medical BV
GEM srl
Genzyme Biosurgery Inc.
GluStitch
Graceduty Company Limited
Hartmann Group/ Hartmann USA
Harvest Technologies Corporation
HemCon Medical Technologies, Inc.
Hemostasis, LLC
Human BioSciences, Inc.
HyperBranch Medical Technology, Inc.
Incisive Surgical, Inc.
Innovasa Corporation
Integra Lifesciences Corporation
Johnson & Johnson (Ethicon, Inc., Ethicon Endo-Surgery, Inc.)
Kaketsuken (Chemo-Sero-Therapeutic Research Institute)
Kensey Nash Corporation
Kimberly-Clark Health Care
Kinetic Concepts, Inc.
King Pharmaceuticals, Inc.
Kookbo Chemicals Co., Ltd. (KB Chem.)
Laboratoires Urgo (Urgo Medical)
LifeBond Ltd.
Lohmann & Rauscher
Marine Polymer Technologies
Medafor, Inc.
MedTrade Products, Ltd.
Meyer-Haake GmbH Medical Innovations
Mölnlycke Health Care AB
Morris Innovative
Motex Healthcare Corp.
NeatStitch Ltd.
Nycomed
Ocular Therapeutix, Inc.
Omrix Biopharmaceuticals Inc.
Pfizer Inc.
Pharming Group NV
Piramal Healthcare
Plasma Technologies, Inc.
Pluromed, Inc.
Polyganics
Polyheal Ltd.
ProFibrix BV
Protein Polymer Technologies, Inc.
Resorba Wundversorgung GmbH & Co. KG
Scion Cardio-Vascular, Inc.
Sea Run Holdings
Smith & Nephew plc
St. Jude Medical
Starch Medical, Inc.
Synovis Life Technologies
SyntheMed, Inc.
Teleflex Medical
ThermoGenesis Corporation
Thrombotargets Corp.
Tissuemed Ltd.
Vascular Solutions, Inc.
Vectura Group plc
Vivostat A/S
Wound Care Technologies, Inc.
Z-Medica Corporation
Zimmer
ZymoGenetics, Inc.
APPENDIX: LIST OF COMPANIES
List of Exhibits
Exhibit ES-1: Recent Acquisitions in the
Securement Segment
Exhibit ES-2: Select Introducers of New Securement
Technologies
Exhibit ES-3: Definition of Surgical Closure and
Securement Products
Exhibit ES-4: Incidence of Two Types of Surgical Procedures In the United States with High Requirement for Adjunctive Products for Surgical Closure and Securement
Exhibit ES-5: U.S. FDA-Approved Uses of Sealants,
Glues and Hemostats
Exhibit ES-6: Selected Synthetic and Biological
Sealant Competitors (Non-Fibrin Sealants)
Exhibit ES-7: Selected High-Strength Adhesive
Companies and Their Strategies
Exhibit ES-8: Selected Sealant Product Companies
and Their Strategies
Exhibit ES-9: Worldwide Growth in the Securement
and Closure Market, 2010-2015 (Millions)
Exhibit 1-1: Skin Structure Illustrating Major
Organelles and Skin Layers
Exhibit 1-2: Classification of Wounds by
Morphology
Exhibit 1-3: Severity Classification of Wounds
Exhibit 1-4: Wound Classification by Etiology
Exhibit 1-5: Prevalence of Different Wound Types,
2009
Exhibit 1-6: Criteria for Adjunctive Use of
Hemostats, Sealants, Glues and Adhesion Prevention Products in Surgery
Exhibit 1-7: Surgical Procedures with Potential
for the Use of Hemostats, Sealants, Glues and Adhesion Prevention
Products, Worldwide (Millions). 2009
Exhibit 1-8:
Prevalence of Common Cardiovascular Diseases, 2006 (000)
Exhibit 1-9: Potential for Neurological
Applications, Prevalence of Applicable Disorders (000)
Exhibit 1-10: Potential for Orthopedic
Applications, Frequency of Major Surgical Interventions (000)
Exhibit 1-11: Potential for Urological
Applications, Prevalence of Applicable Disorders (000)
Exhibit 1-12: Potential for Dermal Repair,
Prevalence of Applicable Disorders (000)
Exhibit 1-13: Applications of Fibrin and Other
Sealants
Exhibit 1-14: Surgical Procedures Using Fibrin and
Other Sealant Products
Exhibit 1-15: Surgical Indications for
High-Strength Glues Exhibit 2-1: Factors That Affect Wound Healing
Exhibit 2-2: Timescales for Development of Closure
and Sealant Products
Exhibit 2-3: Variables Associated With Clinical
Evaluation of Closure and Securement and Related Products
Exhibit 3-1: Competitors in the Market for
Sutures, Staples and Other Mechanical Closure Devices
Exhibit 3-2: Worldwide Market Forecast for
Sutures, Staples and Other Mechanical Closure Devices, 2010-2015, USD
Million
Exhibit 3-3: Worldwide Market for Sutures, Staples
and Other Mechanical Closure Devices, Competitor Market Shares, 2009,
USD Million
Exhibit 3-4: Competitors in the Market for Medical
Tapes
Exhibit 3-5: Worldwide Market Forecast for Medical
Tapes, 2010-2015, USD Million
Exhibit 3-6: Worldwide Market for Medical Tapes,
Competitor Market Shares, 2009, USD Million
Exhibit 3-7: Competitors in the Market for
Hemostats
Exhibit 3-8: Worldwide Market Forecast for
Hemostats, 2010–2015, USD Million
Exhibit 3-9: Worldwide Market for Hemostats,
Competitor Market Shares, 2009, USD Million
Exhibit 3-10: Competitors in the Market for Fibrin
and Other Sealants
Exhibit 3-11: Worldwide Market Forecast for Fibrin
and Other Sealants, 2010-2015, USD Million
Exhibit 3-12: Worldwide Market for Fibrin and
Other Sealants, Competitor Market Shares, 2009, USD Million
Exhibit 3-13: Competitors in the Market for
High-Strength Medical Adhesives
Exhibit 3-14: Worldwide Market Forecast for
High-Strength Medical Adhesives, 2010-2015, USD Million
Exhibit 3-15: Worldwide Market for High-Strength
Medical Adhesives, Competitor Market Shares, 2009, USD Million
Exhibit 3-16: Competitors in the Market for
Post-Surgical Adhesion Prevention
Exhibit 3-17: Worldwide Market Forecast for
Post-Surgical Adhesion Prevention, 2010-2015, USD Million
Exhibit 3-18: Worldwide Market for Post-Surgical
Adhesion Prevention, Competitor Market Shares, 2009, USD Million
Exhibit 3-19: Size and Growth of Wound Closure and
Securement Market, World and Selected Countries, 2009
Exhibit 3-20: Wound Closure Market by Product
Segments: The Major American Countries, 2009, USD Million
Exhibit 3-21: Wound Closure Market by Product
Segments, Japan, 2009, USD Millions
Exhibit 3-22: Wound Closure Market by Product
Segments, Korea, 2009, USD Millions
Exhibit 3-23: Wound Closure Market by Product
Segments, Major European Countries, 2009, USD Millions
Exhibit 3-24: Wound Closure Market by Product
Segments, Rest of World, 2009, USD Millions
Exhibit 3-25: Growth Forecast for Closure and
Securement Market, By Country, 2010-2015, USD Millions
Exhibit 3-26: Growth Forecast for Closure and
Securement Market, By Segment, 2010-2015, USD Millions
Exhibit 4-1: Johnson & Johnson Wound Closure
Products Report #S180 Worldwide Surgical Sealants,
Glues, Wound Closure and Anti-Adhesion Markets, 2010-2015 (October 2010)
Price: $3,750
for print or PDF; add $200 to receive for both
Order
online
or via
order
form.
MedMarket Diligence Reports are produced through primary
and secondary research. Data is gathered from published sources on products
and technologies on the market and under development. Clinicians and industry
representatives are interviewed for their knowledge and insights on product
development, market development, clinical practice and trends associated with
the evolving use of technologies. Secondary data is used to corroborate and
support assessments and projections. Reports are written and researched
by industry insiders, whose familiarity with the companies, industry dynamics
and other marketplace specifics facilitate the research process and ensure high
quality and thorough reports.
Or contact: Patrick Driscoll, (949) 859-3401 or patrick <at>
mediligence <dot> com. Refund Policy: Copyright © 2011 MedMarket Diligence, LLC. All rights
reserved. |
Or call
MedMarket Diligence Reports Coverage
|
||||||||
